LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,880 | +524.5% | 4,295 | +724.4% | 0.00% | – |
| Q2 2023 | $3,824 | +31766.7% | 521 | -82.8% | 0.00% | – |
| Q1 2023 | $12 | +33.3% | 3,037 | +8.4% | 0.00% | – |
| Q4 2022 | $9 | -99.9% | 2,801 | -15.3% | 0.00% | – |
| Q3 2022 | $13,000 | +30.0% | 3,306 | +5.1% | 0.00% | – |
| Q2 2022 | $10,000 | +900.0% | 3,146 | +1279.8% | 0.00% | – |
| Q1 2022 | $1,000 | -92.3% | 228 | -91.8% | 0.00% | – |
| Q4 2021 | $13,000 | +116.7% | 2,786 | +270.5% | 0.00% | – |
| Q3 2021 | $6,000 | – | 752 | +1878.9% | 0.00% | – |
| Q2 2021 | $0 | – | 38 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,321,403 | $20,869,000 | 0.71% |
| Integral Health Asset Management, LLC | 30,000 | $274,000 | 0.08% |
| FARALLON CAPITAL MANAGEMENT LLC | 810,500 | $7,392,000 | 0.03% |
| Orbimed Advisors | 113,500 | $1,035,000 | 0.01% |
| Alyeska Investment Group, L.P. | 85,360 | $778,000 | 0.01% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2,287,289 | $20,105,000 | 0.00% |
| Laurion Capital Management LP | 20,918 | $191,000 | 0.00% |
| FMR LLC | 2,037,831 | $18,585,000 | 0.00% |
| BlackRock Inc. | 17,999 | $164,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 38 | $0 | 0.00% |